Duncan Gregory Scott 4
4 · CorMedix Inc. · Filed Sep 18, 2025
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
Duncan Gregory Scott
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2025-09-16−13,333→ 6,667 totalExercise: $8.32Exp: 2031-01-10→ Common Stock (13,333 underlying) - Exercise/Conversion
Common Stock
2025-09-16$8.32/sh+13,333$110,931→ 38,333 total
Footnotes (1)
- [F1]These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.